Expert Interview
A Second Look: Discussing Sarepta Therapeutics’ Topline Three-Year EMBARK Results for ELEVIDYS in Ambulatory Duchenne Patients
Ticker(s): SRPTInstitution: University of Washington
- Professor of Neurology, Medicine and Biochemistry and Director of the Senator Paul D. Wellstone Muscular Dystrophy Research Center
- Manages a lab of 15 scientists focused on conducting cutting edge research to develop treatments for muscular dystrophy
- Author of many papers on DMD and the book "Duchenne Muscular Dystrophy: Advances in Therapeutics (Neurological Disease and Therapy)"
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
